HIV infection, tuberculosis and non-tuberculous mycobacteria.
Churchyard
G J
GJ
Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, UK.
Grant
A D
AD
D000995:Antitubercular Agents / Q000627:therapeutic use; D018563:Disease Notification; D015658:HIV Infections / Q000150:complications* / Q000453:epidemiology / Q000517:prevention & control; D006801:Humans; D007165:Immunosuppression Therapy; D015994:Incidence; D015269:Mycobacterium avium Complex / Q000472:pathogenicity; D019909:Mycobacterium kansasii / Q000472:pathogenicity; D009169:Mycobacterium tuberculosis / Q000472:pathogenicity; D015995:Prevalence; D013019:South Africa / Q000453:epidemiology; D016896:Treatment Outcome; D018088:Tuberculosis, Multidrug-Resistant; D014397:Tuberculosis, Pulmonary / Q000150:complications* / Q000453:epidemiology / Q000517:prevention & control
D000995:Antitubercular Agents